• Latest Posts
In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors

In Depth 15 Oct 2019

Four New Technologies That Will Change Cancer Treatment

CAR-T Promise for Patients with Solid Tumors

Interview 13 Jun 2018

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

Belgian Biotech Gets a €46M Boost to Keep up in the CAR-T Race


“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“

Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

In Depth 11 Jul 2017

Regenerating the Body With Stem Cells – Hype or Hope?

Celyad gets FDA Fast Track to Tackle Heart Failure with Cell Therapy

Novartis Gains Access to Celyad’s allogenic CAR-T cell patents